Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,396
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
for
Proteinuric Kidney Disease
Location: Arnold MD, Washington D.C. DC, Lutherville MD,
Sponsor: Maze Therapeutics
Sex: All
Age: 18 - 68
Code: NCT06830629
Phase2, Recruiting
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
for
Symptomatic Venous Thromboembolism (VTE)
Location: Annapolis MD, Baltimore MD, Hershey PA, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07213778
Phase3, Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Prospective Study to Assess a Diagnostic Aid for Cancer
for
Cancer
Location: Annapolis MD, York PA, Harrisburg PA, Wyomissing PA,
Sponsor: Harbinger Health
Sex: All
Age: 45+
Code: NCT07046260
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Annapolis MD, Fort Belvoir VA, Leesburg VA, Richmond VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Annapolis MD, Washington D.C. DC, Charlottesville VA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase3, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Annapolis MD, Philadelphia PA, Doylestown PA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase2, Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Annapolis MD, Largo MD, Silver Spring MD, Columbia MD,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase3, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: Annapolis MD, Washington D.C. DC, Fairfax VA,
Sponsor: Greenwich LifeSciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05232916
Phase3, Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma,
Location: Annapolis MD, Largo MD, Silver Spring MD, Columbia MD,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07392892
Phase2, Phase3, Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Annapolis MD, Largo MD, Silver Spring MD, Columbia MD,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07144280
Phase3, Recruiting
Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)
for
Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment,
Location: Annapolis MD, Glen Burnie MD, Greenbelt MD, Columbia MD,
Sponsor: Brainsway
Sex: All
Age: 22 - 68
Code: NCT04455646
Recruiting
Long-Term Stability of the Glide Control Strategy
for
Upper Limb Amputation Above Elbow,
Location: Annapolis MD, Baltimore MD, Silver Spring MD,
Sponsor: Infinite Biomedical Technologies
Sex: All
Age: 18+
Code: NCT07222085
Recruiting
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy